Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
XTL Biopharmaceuticals Ltd ADR
XTLBCurrent price
1.86 USD
+0.011 USD (+0.62%)
Last closed
1.81 USD
Company
www.xtlbio.com
ISIN
US98386D3070
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
12 805 290 USD
Yield for 12 month
+118.82 %
1Y
3Y
5Y
10Y
15Y
XTLB
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel. Address: 26 Ben-Gurion St., Ramat Gan, Israel, 5112001
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
30 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
-459 000 USD
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
-460 000 USD
Current Quarter
–
Last Quarter
–
Key Figures XTLB
1 year
3 years
5 years
10 years
EBITDA
-764 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-13.78 %
PEG Ratio
–
Return On Equity TTM
-13.07 %
Wall Street Target Price
30 USD
Revenue TTM
–
Book Value
0.005 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.03 USD
Diluted Eps TTM
-0.03 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
-76 %
Profit Margin
–
Dividend Analytics XTLB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History XTLB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:5
Payout Ratio
–
Last Split Date
10.02.2017
Dividend Date
10.02.2017
Stock Valuation XTLB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
11.3069
Price Book MRQ
4.7339
Financials XTLB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators XTLB
For 52 weeks
0.76 USD
4.99 USD
50 Day MA
2.33 USD
Shares Short Prior Month
14 674
200 Day MA
2.17 USD
Short Ratio
1.44
Shares Short
8 556
Short Percent
1.02 %
BeatStart